0
0.5
1
1.5
2+
Mortality
89%
Improvement
Relative Risk
Hospitalization
62%
primary
ED visit
-11%
Sotrovimab Aggarwal et al. EARLY TREATMENT
Is early treatment with sotrovimab beneficial for COVID-19?
PSM retrospective 10,036 patients in the USA (Oct - Dec 2021)
Lower mortality (p=0.048) and hospitalization (p=0.0021)
c19early.org
Aggarwal et al., The J. Infectious Dis.., Apr 2022
Favors sotrovimab
Favors control